Dr. John Mendlein, General Manager Adnexus Therapy Inc (Adnexus), a private biotechnology company, must decide whether to continue the negotiations with the acquisition of Bristol-Myers Squibb (BMS) after a successful six months and to continue to cooperate with the planned IPO Adnexus. "Hide
by Vicki L. Sato, Rachel Gordon Source: Harvard Business School 17 pages. Publication Date: November 11, 2008. Prod. #: 609015-PDF-ENG
Related Case Solutions & Analyses:
Cold Opportunity (A): The Nils Bergqvist Story
American National Red Cross (B)
Lincoln Industries
Apple Computer–John Sculley Chairman & CEO–Presentation to ISMP Participants July 6 1992 Video
Chipotle Mexican Grill, Inc.: Food with Integrity
LinkedIn Corporation, 2012
LG Investments, LLC: A Family Business in Generational Transition (B)
Engstrom Auto Mirror Plant: Motivating in Good Times and Bad, Spanish Version
Students Helping Honduras
Poland’s Transition to Democracy (Summary Case)
